Translational and clinical research applications of long-read sequencing technologies in oncology
Hear Marilyn Li share data from recent pilot studies at Children's Hospital of Philadelphia (CHOP), leveraging Oxford Nanopore sequencing for ultra-rapid classification of acute leukaemia and intraoperative analysis of central nervous system (CNS) tumours.
Please note: This is independent, investigator-led research using Oxford Nanopore technology. Oxford Nanopore products are for research use only, and not for use in diagnostic procedures.
This talk was originally presented at AGBT 2026. Register below to watch on demand.
View on demand
Meet the speakers
Marilyn Li, Vice Chief of the Division of Genomic Diagnostics and Director of Cancer Genomic Diagnostics, Children's Hospital of PhiladelphiaMarilyn M. Li, M.D. is Vice Chief of Division of Genomic Diagnostics and Director of Cancer Genomic Diagnostics at Children’s Hospital of Philadelphia. She is also Professor of Pathology and Pediatrics at University of Pennsylvania, Perelman School of Medicine. Dr. Li is board-certified by the American Board of Medical Genetics and Genomics. Her primary research interest is the clinical application of high-throughput multiomics technologies in cancer research and clinical diagnosis to facilitate precision cancer care. She is the recipient of many prestigious awards, has published over 150 peer-reviewed articles, and has given over 100 invited presentations and grant rounds nationally and worldwide.
